| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| CF Corporation (CFCOU) (u) | Citigroup/ BofA Merrill Lynch/ Credit Suisse | 60.00 | $10.00 | $10.00 | $600.00 | n.a. |
| Gemphire Therapeutics (GEMP) | Jefferies/ Cowen and Company | $60.00 | n.a. | |||
| M III Acquisition (MIIIU) | Cantor Fitzgerald & Co. | 17.50 | $10.00 | $10.00 | $175.00 | n.a. |
| Performance Health Holdings (PHC) | Credit Suisse/ Baird | $100.00 | n.a. | |||
| PhaseRx (PZRX) | Laidlaw & Company (UK) Ltd. | $30.00 | n.a. | |||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Cancer Prevention Pharmaceuticals (CPP) | Aegis Capital | 1.92 | $12.00 | $14.00 | $25.00 | n.a. |
| Monster Digital (MSDI) | Axiom Capital Management/ WestPark Capital | 1.00 | $15.00 | $15.00 | $15.00 | n.a. |
| SiteOne Landscape Supply (SITE) | Deutsche Bank Securities/ Goldman Sachs/ UBS Investment Bank | $100.00 | n.a. | |||
| Turning Point Brands (TPB) | Cowen and Company/ FBR | $100.00 | n.a. | |||
| Yintech Investment Holdings Limited (YIN) | Jefferies | 7.50 | $12.50 | $14.50 | $101.25 | 2-Stars |
| n.a. (not available) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of April 18, 2016 | Manager(s) | Offered | Raised | Price | 4/22/16 | Change |
| American Renal Associates Holdings (ARA) | BofA Merrill Lynch/ Barclays/ Goldman Sachs/ Wells Fargo Securities/ SunTrust Robinson Humphrey Leerink Partners | 7.50 | $165.00 | $22.00 | $26.60 | 20.91% |
| MGM Growth Properties LLC (MGP) | BofA Merrill Lynch/ J.P. Morgan/ Morgan Stanley/ Evercore ISI/ Barclays/ Citigroup/ Deutsche Bank Securities | 50.00 | $1,050.00 | $21.00 | $22.00 | 4.76% |
| SecureWorks (SCWX) | BofA Merrill Lynch/ Morgan Stanley/ Goldman Sachs/ J.P. Morgan | 8.00 | $112.00 | $14.00 | $14.00 | 0.00% |
